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• Does AMR inwildlife reﬂect exposure to
human or livestock wastes?
• AMR patterns in E. coli from birds and
mammals varied with site, season and
host.
• Colistin resistance and ESBL/AmpC ac-
tivity high in wildlife exposed to
human waste.
• Our data question the use of wildlife as
sentinels of anthropogenic environmen-
tal AMR.
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The isolation of antimicrobial resistant bacteria (ARB) fromwildlife living adjacent to humans has led to the sug-
gestion that such antimicrobial resistance (AMR) is anthropogenically driven by exposure to antimicrobials and
ARB. However, ARB have also been detected inwildlife living in areaswithout interactionwith humans. Here, we
investigated patterns of resistance in Escherichia coli isolated from 408 wild bird and mammal faecal samples.
AMR and multi-drug resistance (MDR) prevalence in wildlife samples differed signiﬁcantly between a Sewage
Treatment Plant (STP; wastes of antibiotic-treated humans) and a Farm site (antibiotic-treated livestockwastes)
and Central site (no sources of wastes containing anthropogenic AMR or antimicrobials), but patterns of resis-
tance also varied signiﬁcantly over time and between mammals and birds. Over 30% of AMR isolates were resis-
tant to colistin, a last-resort antibiotic, but resistancewas not due to themcr-1 gene. ESBL andAmpC activitywere
common in isolates from mammals. Wildlife were, therefore, harbouring resistance of clinical relevance. AMR
E. coli, including MDR, were found in diverse wildlife species, and the patterns and prevalence of resistance
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were not consistently associatedwith site and therefore different exposure risks. We conclude that AMR in com-
mensal bacteria of wildlife is not driven simply by anthropogenic factors, and, in practical terms, this may limit
the utility of wildlife as sentinels of spatial variation in the transmission of environmental AMR.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Antimicrobial resistance (AMR) has existed formillions of years, and
is an inevitable evolutionary consequence of microbial competition in
the environment (D'Costa et al., 2011; Davies and Davies, 2010;
Martinez, 2009). While the increasing prevalence of AMR in clinically
important and commensal bacteria in both humans and livestock can
be attributed largely to selection through the use of antimicrobials
(Ibrahim et al., 2016; Karesh et al., 2012), AMR has also been reported
in the commensal bacteria of wildlife (Arnold et al., 2016). Commensal
bacteria have the potential to act as reservoirs of resistance genes, con-
tributing to the development of AMR in pathogens by horizontal trans-
mission (Arnold et al., 2016; Taylor et al., 2011; von Wintersdorff et al.,
2016). AMR is a problem in human and veterinarymedicineworldwide,
inhibiting the treatment of bacterial infections and estimated to be re-
sponsible for 25,000 preventable human deaths in Europe annually
(Marston et al., 2016) and an estimated global economic cost of 100 tril-
lion USD by 2050 if not addressed (O'Neill, 2016). Thus, there is increas-
ing interest in the environment, including wildlife, as both a source of
clinically relevant AMR and in order to better understand the effects of
anthropogenically-derived antimicrobial pollution and resistance in
ecosystems (Arnold et al., 2016; Carroll et al., 2015; Huijbers et al.,
2015).
It is often assumed that antimicrobial-resistant bacteria (ARB) in
wildlife result from contact with anthropogenic sources such as farms
and human waste that pollute the environment with AMR bacteria
and/or with antimicrobials (Allen et al., 2010; Clarke and Smith, 2011;
Radhouani et al., 2011). Farms on which manure and slurry can be con-
taminatedwithARB, antibiotics (or theirmetabolites) andother selective
drivers of AMR are important habitats for many small mammals and
birds, as are sewage treatment plants (STPs) where some birds and
mammals feed directly from the bioprocessers (reviewed in Arnold
et al., 2016). Run-off from farms, slurry tanks and manure-fertilised
ﬁelds, along with sewage efﬂuent, can result in antimicrobial drug and
ARB contamination of local water courses and land (Fahrenfeld et al.,
2013). Consequently, it is unsurprising that ARB have been found in
wild animals in close contact with humans (Allen et al., 2011; Bondo
et al., 2016; Furness et al., 2017; Gilliver et al., 1999).
Assigning the source and directionality of AMR dissemination is
challenging. Even within wildlife populations living in close contact
with humans or livestock, or at least their wastes, there is little evidence
directly linking an anthropogenic source of AMR with speciﬁc patterns
of AMR and/or resistance genes. For example, few overlaps in resistance
patterns and AMR genes were found between E. coli isolated fromwild-
life living on or near dairy farms and dairy cattle in England (Arnold
et al., 2016; Wu et al., 2018). Whereas wild rodents nearer to a river re-
ceiving sewage efﬂuent excreted more resistant E. coli than inland ani-
mals (Furness et al., 2017), this was an association lacking evidence of
a clear transmission pathway. Other highly mobile taxa such as birds
also carry ARB that have not been attributed to any particular anthropo-
genic source (Guenther et al., 2017; Schauﬂer et al., 2016). Moreover,
AMR has been detected in wildlife living in remote and isolated loca-
tions with no obvious contact with the wastes of antimicrobial-treated
humans or livestock (Cristobal-Azkarate et al., 2014). Thus, although
transmission of AMR fromhumans or livestock towildlife via direct con-
tact with sewage, slurry or faeces, has been suggested, the empirical ev-
idence is lacking or contradictory. Species or ecological guilds with
different dispersal patterns, resource requirements and foraging
behaviours are likely to have different roles in the evolution and dis-
persal of AMR (Arnold et al., 2016).We argue that the efﬁcacy ofwildlife
species as sentinels of environmental transmission of AMRwill vary de-
pending on the spatial and temporal scales of interest.
In this study, three nearby communities of small wild rodents and
birds were investigated for evidence of AMR in faeces. The antimicro-
bials used to screen for resistance were chosen as they represent a
range of antibiotic classes of medical and veterinary interest. For
example, cefpodoxime resistance is seen as an indicator of extended
spectrum beta-lactamase (ESBL) or AmpC beta-lactamase producing
bacteria which cause signiﬁcant problems in human medicine espe-
cially with urinary tract infections (Rawat and Nair, 2010). Colistin re-
sistance is also of relevance due to colistin being an antibiotic of last
resort. The sites for sampling were chosen to represent different expo-
sures to wastes and thus potentially different selection pressures for
AMR: a dairy farm with antimicrobial-treated livestock, a STP contain-
ing waste from humans treated by antimicrobials and an area of park-
land and neighbouring arable ﬁeld edge with no obvious sources of
waste containing antimicrobials or ARB. We sampled wildlife species
typical for small woodlands, farmland and hedgerow habitats in the
UK; small rodents including wood mice Apodemus sylvaticus, bank
volesMyodes glareolus and a number of bird species.
The overall aim of this study was to investigate the role of environ-
mental contamination in the patterns of AMR found in wildlife. We ad-
dressed whether the spatial location where wild birds and mammals
were sampled, including proximity to human and livestock wastes, ex-
plained variation in: 1) prevalence and genomic diversity of AMR E. coli
in birds andmammals; 2) patterns of AMR andMDRprevalence in E. coli
isolates; and 3) prevalence of phenotypic resistance tomedically impor-
tant antimicrobials and the resistance genes responsible.
2. Material and methods
2.1. Study sites
Three nearby study sites in the East Midlands of England, on a
1200m transect, were selected (Fig. S1), based on their differing poten-
tial exposure to human and livestock sources of AMR and antimicrobial
drugs. The ‘Farm site’ was a small woodland and hedgerows immedi-
ately adjacent to a dairy farm that received run-off from farm buildings
and livestock faeces potentially contaminated with AMR bacteria and
antimicrobials. The ‘Central site’, around 600m from the Farm site, com-
prised an arboretum and neighbouring hedgerow edging an arableﬁeld.
It was not adjacent to known sources of human or livestock waste. The
‘STP site’ was a small sewage treatment plant around 450–600 m from
the Central-site, comprising the land and hedgerows surrounding all
the tanks and trickling ﬁlters making up the STP and hedgerows adja-
cent to the pipe where treated water outﬂowed into a local stream. All
the sites were close enough to share common environmental traits
and weather. Conversely, the three sites were far enough apart, with
physical barriers to dispersal (roads and a railway line), such that
most of the species sampled would not regularly move between the
sites.
2.2. Sampling wildlife
All sampling took place between July and August (‘Summer’), and
October and November (‘Autumn’) 2016 and was subject to full ethical
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review (see Supplementary material). Sampling occurred each week
per month per site, but mammals and birds were not captured simulta-
neously to avoid excessive disturbance. Small mammals were trapped
in Longworth or similar live, small mammal traps with shrew escape
holes. The traps were sterilised between sites, ﬁlled with sterile hay as
bedding andmixed grain and carrot or apple as food andwater sources.
Traps were placed at 5 m intervals and checked daily. Faeces were col-
lected with a sterile swab into a sterile sampling tube for transport to
the laboratory. The species of each rodent caught, the date and trap lo-
cation were recorded.
Wild birds were caught in mist nets, under licence from the British
Trust for Ornithology (BTO), located along and across hedgerows and
patches of woodland within each study site. Each capture location was
selected to overlap with trapping sites for small mammals (above)
and was pre-baited for at least 3 days with bird feeders containing
mixed seed. After capture, each bird was placed on its own into a single
use brown paper bag for up to 20min in order to collect a faecal sample.
The bird was then ﬁttedwith a BTO leg ring, before being released. Ster-
ile swabs were used to remove faeces from the bags into sterile sam-
pling tubes. If the same bird was caught more than once on the same
day the faecal samples were pooled. In addition, feral pigeons, which
formed a large ﬂock at the Farm-site, were sampled for faeces post-
mortem after shooting as part of pest control. Table S3 shows the
range of species caught. The foraging ecology of the species did not ex-
plain any of the patterns of AMR or MDR observed (see Supplementary
material).
2.3. Isolation and AMR characterisation of presumptive E. coli isolates
Phenotypic resistance to eight antibiotics was determined ﬁrst
by plating on antibiotic-supplemented media or by disk diffusion.
Faecal samples (0.5 g) were incubated in buffered peptone water
(BPW) at 37 °C for 18 h and 100 μl was spread onto Tryptone Bile
X-Glucuronide Medium (TBX; Oxoid, UK) agar supplemented
with; ampicillin (10 μg/ml), apramycin (30 μg/ml), colistin (4 μg/
ml) or ciproﬂoxacin (1 μg/ml) or without antibiotics and incubated
at 37 °C for 18 h. Presumptive E. coli (blue/green) colonies were
taken forward for further characterisation.
One presumptive antibiotic resistant E. coli colony per plate ob-
tained from the initial screening was then tested for resistance to
other antibiotics using disc diffusion assays. Brieﬂy, isolates were
cultured in BPW at 37 °C for 18 h. Samples (100 μl) were spread
plated onto Muller-Hinton agar (MH; Oxoid, UK) and left to dry.
Six antibiotic discs impregnated with ampicillin (10 μg/ml), tetracy-
cline (3 μg/ml), apramycin (15 μg/ml), trimethoprim (2.5 μg/ml),
imipenem (10 μg/ml) and cefpodoxime (10 μg/ml), were placed on
the agar and the plates were incubated for 18 h at 37 °C. After incu-
bation the diameter of the zone of clearance around each disc was
measured and isolates were classiﬁed as resistant if the zone was
less than or equal to published breakpoints (EUCAST, 2016).
2.4. Characterisation and ERIC-PCR genotyping of E. coli isolates
A representative subsample of presumptive E. coli isolated from
mammals from each site and every presumptive E. coli isolated from
birds were subject to rRNA PCR and sequencing (Srinivasan et al.,
2015). BLAST searches conﬁrmed all were Escherichia, and the vast ma-
jority clearly E. coli. In order to identify any patterns of genotypic simi-
larity among E. coli by spatial location or host (mammal/bird), we
used ERIC-PCR. Twenty-four resistant E. coli isolates from mammals at
each sample site and all the resistant E. coli isolates from birds (total
91 samples) were subjected to ERIC-PCR (Ibrahim et al., 2016;
Versalovic et al., 1991). DNA (diluted 1:100) extracted from the E. coli
isolates, 12.5 μl of PCR Master Mix Plus (Qiagen, UK), 5 μM of the each
ERIC primer (Table S1), 2 μl of Coral Load Dye (Qiagen, UK) and sterile
molecular grade water to 25 μl. The PCR parameters for the ERIC-PCR
are found in Table S1.
2.5. Analysis of ESBL and AmpC resistance in cefpodoxime-resistant E. coli
Cefpodoxime resistant isolateswere tested for ESBL or AmpC activity
using the AmpC & ESBL Detection Set (Mast Group, UK). Brieﬂy, over-
night liquid cultures of cefpodoxime resistant isolates were spread
plated ontoMHagar and left to dry before discs containing cefpodoxime
10 μg (A), cefpodoxime 10 μg + ESBL inhibitor (B), cefpodoxime 10 μg
+AmpC inhibitor (C) ad cefpodoxime10 μg+ESBL andAmpC inhibitor
(D) were added. Comparison of the zones of clearance enabled ESBL
and/orAmpC resistant bacteria to be identiﬁedusing themanufacturer's
calculator (Mast Group, UK).
2.6. DNA extraction and PCR parameters
DNAwas extracted from E. coli by heat-lysis. One colony was placed
in 10 μl of sterile molecular grade water and heated at 95° for 10 min.
Samples were centrifuged (13,000 ×g; 3 min) and the supernatant re-
moved. The supernatant was stored at−20 °C until used as template
DNA for subsequent PCR reactions. PCR ampliﬁcations (apart from
ERIC-PCR) were carried out in 20 μl reaction mixtures comprising of
10 μl of PCR Master Mix Plus (Qiagen, UK): 0.5 μM of each primer, 2 μl
of Coral Loading Dye (Qiagen, UK) and molecular grade sterile water
to 20 μl. See Table S1 for primers and PCR cycling parameters.
2.7. Molecular characterisation of colistin and ciproﬂoxacin resistant E. coli
E. coli isolates with phenotypic colistin and ciproﬂoxacin resistance
were further characterised. DNA from ciproﬂoxacin and colistin-
resistant colonies was diluted 1:100 and used as template DNA for
PCR to amplify the gyrA and if present the transposable mcr-1 gene
(Liu et al., 2016). For ciproﬂoxacin resistant isolates DNA was puriﬁed
from agarose gels using a Gel DNA Extraction Kit (ZymoResearch, UK)
and sequenced. The sequences were aligned and compared against
E. coli K12 using CLC SequenceCe Viewer (Qiagen) to identify speciﬁc
point mutations in gyrA associated with ciproﬂoxacin resistance. As a
positive control for colistin resistance, DNA harbouring the mcr-1 gene
was used.
2.8. Statistical analyses
Binomial logistic regression models were used to ascertain the ef-
fects of site (Farm, Central and STP), season (Summer = Jul/Aug,
Autumn = Oct/Nov) and taxa (bird or mammal) on the prevalence of
E. coli in faecal samples andprevalence of resistance, i.e. if E. coliwere re-
sistant to one ormore antibiotic (‘AMR ≥ 1 antibiotic’) orMDR (resistant
to three ormore antibiotics). All of these analyseswere carried out using
SPSS v.24.
The ERIC-PCR gel image was analysed using a Gel-Doc XR system
(Bio-Rad, UK) (Ibrahim et al., 2016). Using GelCompar II (Applied
Maths) a dendrogram was generated from the comparison of ERIC-
PCR proﬁles, using theDice coefﬁcient, and clustered by the unweighted
pair group method with arithmetic averages (UPGMA) with 1.5% of
optimization and 1.5% of tolerance. Molecular variance framework
analysis (AMOVA) (Excofﬁer et al., 1992) was used to analyse the con-
ﬁdence of the selected similarity threshold and the signiﬁcance of clus-
ters. The AMOVA calculation was carried out using GenAlEx v 6.5b5
software (Peakall and Smouse, 2006). The signiﬁcance was examined
with the calculation of ΦPT, a measure of population differentiation
that suppresses intra-individual variation. In the case of AMOVA, the
null hypothesis (H0;ΦPT = 0) meant that there was no genetic differ-
ence among the populations and the alternative hypothesis (H1;ΦPT N
0) meant there were genetic differences among the populations.
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3. Results
3.1. E. coli in rodent and avian samples
In total, 125 faecal samples from bank voles, 15 from ﬁeld voles and
89 from wood mice were collected. A further 96 faecal samples were
collected from traps from which small mammals had escaped, and
were recorded as ‘unknown’ (see Table S2).We collected 83 avian faecal
samples from 18 different species.
Overall E. coli were isolated from 66% (269/408) of faecal samples
(Fig. 1). The prevalence of E. coliwas explained by site, season and taxa
(Table 1a). Samples collected from the Central (63%; n= 145) and STP
sites (64%; n= 125) did not differ signiﬁcantly. Samples collected from
the Farm Site (prevalence = 71%; n = 138) were signiﬁcantly more
likely to contain E. coli than those from the Central Site (Table 1a;
Fig. 1). Mammalian samples were signiﬁcantly more likely to contain
E. coli (prevalence = 74%; n= 325) than avian samples (33%; n= 83)
(Table 1a). Samples collected in Summer (prevalence = 73%; n= 227)
were signiﬁcantly more likely to contain E. coli than those collected in
Autumn (57%; n= 181) (Table 1a).
3.2. Genotyping of E. coli isolates by ERIC-PCR
A selection of AMR E. coli representing different hosts and sites were
compared by ERIC-PCR (Fig. 2). Cluster analysis suggested ﬁve main
groups of isolates at a 50% similarity threshold (indicated as I–V in
Fig. 2). Cluster signiﬁcance analysis demonstrated these were non-
overlapping and hence genomically independent groups (cluster signif-
icance ΦPT = 0.036; p b 0.001). Each larger cluster (II–V) contained
E. coli from a range of hosts and sites with no obvious association be-
tween their AMRpattern andwhich cluster the isolates resided in.How-
ever, there was a tendency towards certain clusters containing isolates
from predominantly one site: cluster II with Farm Site, cluster III with
Central Site and cluster V with STP Site. Given an expected probability
of 0.33, binomial tests indicated that the proportion (0.69) of Farm
Site samples in Cluster II was signiﬁcantly higher than expected (p =
0.0002), as was the proportion of Central Site samples (0.62) in Cluster
III (p=0.033) and the proportion of Farm Site samples (0.75) in Cluster
V (p= 0.0006).
3.3. Antimicrobial resistance
The prevalence of AMR was expressed as the percentage of samples
from which E. coli was isolated (on the TBX plate without antibiotics)
that also contained at least one isolate resistant to at least one of the an-
tibiotics tested (AMR ≥ 1). The overall prevalence of AMR E. coliwas 54%
(n=262) andwas signiﬁcantly explained by amodel that included sea-
son, taxa and site (Table 1b). AMR prevalence in samples from the STP
was 61.3% (n=80) whichwas signiﬁcantly higher than the prevalence
of resistance in samples from the Central Site (50.0%; n=86) (Table 1b;
Fig. 3a). Prevalence in samples from the Farm site was 52.1% (n= 96)
and did not signiﬁcantly differ from that in Central Site samples
(Table 1b).
E. coli from samples collected in Summer (prevalence = 65.4%;
n = 159) were signiﬁcantly more likely to be resistant than those
collected in Autumn (36.9%; n = 103) (Table 1b). There was a ten-
dency (p= 0.056; Table 1b) for mammalian faecal samples to have
a higher prevalence (55.7%; n = 235) of resistant E. coli than avian
samples (40.7%; n = 27).
3.4. Multi-drug resistance (MDR)
For the purpose of this studyMDRwas deﬁned as resistance to three
or more of the eight classes of antibiotics tested. Overall, 80.3% (n =
142) of the AMR E. coliwere MDR. A model including taxa and site sig-
niﬁcantly explained MDR prevalence (Table 1c). Prevalence in samples
from the Farm site (66.0%; n= 50), was signiﬁcantly lower than from
the Central site (83.7%; n = 43). Prevalence of MDR in samples from
the Central and STP sites (91.8%; n = 49) did not differ signiﬁcantly
(Fig. 3b; Table 1c). E. coli from samples collected from mammals
(prevalence = 84.7%; n = 131) were signiﬁcantly more likely to be
MDR than those collected from birds (27.3%; n=11) (Table 1c). Season
(MDR prevalence in Summer = 77.9%; n = 104 and in Autumn =
86.8%; n= 38) was non-signiﬁcant so was excluded from the model.
Individual E. coli isolates were resistant to up to seven different anti-
biotics (Fig. 3c). There was no obvious difference in MDR proﬁles be-
tween the different sites tested (Table 2).
3.5. Prevalence of ESBL or AmpC producing E. coli
All isolates resistant to cefpodoxime were further investi-
gated for ESBL or AmpC production. From the 53 cefpodoxime
Table 1
Final binomial logistic regressionmodel outputs explaining prevalence of a) E. coli; b)AMR
≥ 1 antibiotic; c)MDR (AMR ≥ 3 antibiotics). The coefﬁcients for the Site variable are com-
pared to the Central Site, for the Taxa variable was compared to birds and for the Season
variable was compared to Autumn.
Nagelkerke R2 χ2 (df) Wald (df) p-Value Odds ratio 95% C.I.
a) E. coli 21% 67.50 (4) b0.0001
Site:
Farm
STP
16.21 (2)
15.07 (1)
0.23 (1)
b0.0001
b0.0001
0.63
3.51
1.14
1.86–6.60
0.67–1.93
Taxa 45.75 (1) b0.0001 9.26 4.86–17.66
Season 3.89 (1) 0.048 1.57 1.00–2.46
b) AMR 14.4% 29.97 (4) b0.0001
Site:
Farm
STP
4.75 (2)
1.17 (1)
4.742 (1)
0.093
0.28
0.029
1.44
2.11
0.74–2.79
1.08–4.73
Taxa 3.64 (1) 0.056 2.48 0.98–6.32
Season 23.93 (1) b0.0001 3.96 2.28–6.89
c) MDR 25.9% 40.91 (4) b0.0001
Site:
Farm
STP
8.02 (2)
0.05 (1)
7.07 (1)
0.018
0.82
0.008
1.09
3.37
0.51–2.34
1.38–8.26
Taxa 14.30 (1) b0.0001 12.53 3.38–46.43
Season 0.57 (1) 0.45 1.34 0.63–2.84
Fig. 1. Inter-site variation in the percentage prevalence of faecal samples testing positive
(solid blue bars) or negative (orange hatched bars) for a) E. coli. Boxes on the bars show
the number of samples in each category.
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resistant E. coli, six were ESBL, 22 were AmpC and six were pos-
itive for both ESBL and AmpC production (Table 3). Across all
samples, there was a signiﬁcant difference between the sites in
the number of isolates testing positive for AMPC and/or ESBL,
with the highest number at the STP site (χ2 (2) = 6.59, p =
0.034; Table 3).
Fig. 2. ERIC proﬁle of E. coli isolated from both small mammals and birds at Farm site (light green, mammals; dark green birds) Central site (red, mammals; dark red, birds) and STP site
(light purple,mammals; dark purple, birds). Horizontal lines demonstrate signiﬁcant clusters (I–V) based on 50% cut-off (vertical line). Red cells demonstrate resistance to each antibiotic:
Amp – ampicillin; Cef – cefpodoxime; Col – colistin; Apra – apramycin; Imi – imipenem; Trim – trimethoprim; Tet – tetracycline; Cip – ciproﬂoxacin.
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3.6. Genotypic analysis of ciproﬂoxacin and colistin resistant isolates
Ciproﬂoxacin resistant E. coliwere further characterised by sequence
comparison with a known sensitive strain of E. coli (K-12) and four of
amino acid changes were observed (Fig. 4). All colistin resistant isolates
were subjected tomcr-1 PCR and nonewere found to be positive for this
gene, suggesting resistance is derived from other ARGs.
4. Discussion
AMR, including MDR, was common among the commensal E. coli of
the wildlife studied, but clear patterns in resistance were not seen in
terms of spatial proximity to anthropogenic sources of waste containing
antimicrobials and ARB. Previous studies have suggested that wildlife
could be used as sentinels of environmental AMR (Furness et al., 2017;
Vittecoq et al., 2016). Our study supports this to some extent, although
as with previous work by ourselves and others (Arnold et al., 2016;
Bondo et al., 2016; Gilliver et al., 1999; Literak et al., 2010; Williams
et al., 2011), factors other than geographic distance from the wastes of
antibiotic treated animals or humans clearly inﬂuence AMR. This is
also demonstrated by the wide variations in MDR proﬁles within and
between sites suggesting other factors affecting AMR in these animals
(Table 2). Host taxonomic differences, as well as spatial and temporal
factors, seemed to inﬂuence AMR prevalence. Moreover, ourmodels ex-
plained about 20% of the variance in AMR and MDR, indicating that
other, unmeasured factors, were also important in determining preva-
lence. Thus, there are signiﬁcant caveats to using wildlife as sentinels
of environmental transmission of AMR due to antimicrobials and ARB
in anthropogenic wastes.
Some studies have reported relatively high AMR prevalence inwild-
life collected near AMR sources such as water bodies receiving sewage
efﬂuent or agricultural wastes, compared with more pristine sites
(Bonnedahl et al., 2009; Furness et al., 2017). In our study, a signiﬁcantly
higher prevalence of AMR was observed at the STP (61%) compared
with the other two sites (b53%). That site and site-speciﬁc environ-
ments might be drivers of exposure is supported by the ERIC analysis
that found that genotypes of E. coli showed spatial- rather than host-
speciﬁc clustering (VanderWaal et al., 2014).Multidrug resistance prev-
alence showed somewhat different patterns with the STP (92%) again
having a signiﬁcantly higher MDR prevalence than the farm (66%), but
a similar prevalence to the Central site (84%). If the prevalence and pat-
terns of resistance were driven by exposure to either anthropogenic an-
timicrobials or ARB from humans and/or livestock, a higher prevalence
of resistance would have been expected at the Farm Site as well as the
STP Site, and the prevalence at the Central site might have been ex-
pected to be lower than both of the other two sites. However, this was
not the case (see also (Carter et al., 2018)).
4.1. Host taxa and temporal variation
Taxonomic differences in both the prevalence of samples containing
E. coli and the prevalence of AMR and MDR were observed. Mammals
(74%) were signiﬁcantly more likely to be carrying E. coli than birds
(33%), with a prevalence of 66% overall. Host taxonomic differences in
E. colimay reﬂect the relatively small size of faecal samples from birds
and their tendency to dry out, but might also simply reﬂect the relative
contribution of E. coli to the normal gut biota of very different taxa. The
prevalence of phenotypic AMR (expressed as the percentage of samples
that contained resistant E. coli)was 54% overall, with amarginally higher
prevalence in mammalian (56%) than avian (41%) samples (p=0.056).
Fig. 3. Site-speciﬁc patterns of resistance in E. coli isolates: a) AMR: The percentage of
faecal samples which contained E. coli susceptible to ≥1 antimicrobial (negative =
orange hatched bars) or resistant to one or more antimicrobial drugs (positive = solid
blue bars); b) MDR - the percentage of samples containing E. coli that were resistant to
≥3 antibiotics (positive = resistant = solid blue bars); c) Prevalence of resistance to 1–7
different antibiotics. The sites were Farm, Central and STP.
Table 2
Frequencies of MDR proﬁles for combinations of antibiotics to which E. coli isolates were
resistant for faecal samples collected frombirds andmammals captured at the STP, Central
and Farm sites. Only proﬁles that were found in two or more individuals are presented.
Amp – ampicillin; Cef – cefpodoxime; Col – colistin; Apra – apramycin; Imi – imipenem;
Trim – trimethoprim; Tet – tetracycline; Cip – ciproﬂoxacin.
Antibiotics Farm Central STP Totals
Amp Tet Col 7 8 8 23
Apra Col Tet 2 3 2 7
Amp Cip Tet 5 0 0 5
Amp Tet Cef 0 1 3 4
Amp Tet Trim 0 2 2 4
Amp Apra Tet 1 2 1 4
Col Cef Tet 0 1 2 3
Apra Trim Col 0 0 2 2
Amp Apra Cef 1 1 0 2
Amp Apra Col Tet 2 5 2 9
Amp Tet Trim Col 2 1 3 6
Col Trim Cef Tet 0 1 2 3
Amp Tet Cef Col 0 0 3 3
Amp Cef Trim Col 1 0 2 3
Apra Tetra Cef Col 1 1 0 2
Amp Apra Trim Col 0 2 0 2
Amp Apra Cef Trim Col 3 2 3 8
Amp Col Trim Cef Tet 1 2 4 7
Amp Apra Tet Trim Col 2 0 0 2
Amp Apra Tet Cef Trim Col 1 2 1 4
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Our prevalence of ARB in mammals was similar to that previously re-
ported in the UK (35% and 79% for inland and coastal populations re-
spectively of small mammals) (Furness et al., 2017), but higher than
that reported in similar species from mainland Europe (for example
5.5% AMR in E. coli from rural small mammals in Germany (Guenther
et al., 2010) and 2–12% in a range of wild mammals the Czech
Republic (Literak et al., 2010)). Reported AMR prevalence in wild birds
is similarly diverse, varying both by species and geography (Carter
et al., 2018). For example, a study of AMR in E. coli from gulls across
Europe found a prevalence of 32% overall, but with considerable geo-
graphic variation, from 61% in Spain to 8% in Denmark (Stedt et al.,
2014). Notably, a larger number of avian than mammal species were
sampled, so differences in ecology and diet among species might obfus-
cate comparisons of the relative roles ofmammals and birds in AMR dis-
persal. However, we did not ﬁnd that our, albeit relatively crude, indices
of foraging ecology explained any of the variance in AMR or MDR, but
this remains an area requiring further research.
Furthermore, in our study, as in others (Ahammad et al., 2014;
Bondo et al., 2016; Sun et al., 2012; Williams et al., 2011), E. coli, AMR
and MDR patterns and prevalence varied over time. Temporal variation
in E. coli and resistance patterns might reﬂect changing environmental
conditions (temperature and rainfall), selective drivers (e.g. patterns
in antibiotic usage) and/or food availability (and changing gut biota)
for wildlife as well as differences between the species' population dy-
namics (Waite and Taylor, 2014; Williams et al., 2011). Since sampling
took place during only two seasons, temporal and seasonal patterns in
AMR evolution and dispersal need further study. Despite some limita-
tions, our study lays the foundations for future studies looking a larger
numbers of animals at a wider variety of sites and, ideally, longitudi-
nally, along with direct sampling of the environment for antibiotics
and ARB.
4.2. MDR prevalence and resistance proﬁles
As described in other studies (Arnold et al., 2016; Williams et al.,
2011), many AMR isolates from mammalian wildlife were multidrug-
resistant (MDR). This was likely an outcome of prevalentmobile genetic
elements such as plasmids and transposons (Carroll et al., 2015), but
chromosomal mutations are also common. The prevalence of MDR
(AMR ≥ 3), like overall AMR (AMR ≥ 1), was higher in mammal (85%)
than in bird samples (27%). On the other hand, the large diversity of
MDR proﬁles found (Table 2) suggests only limited MDR transmission
between individuals. Some of these resistances (ciproﬂoxacin) were
found to be derived from chromosomal point mutations and therefore
are not necessarily linked to the other resistances carried by the individ-
ual bacterium. Moreover, MDR prevalence was highest at the STP. It is
tempting, therefore, to speculate that animals at the STP Site were ex-
posed to a wider range of MDR bacteria, plasmids, or antimicrobials,
than animals at other sites. This in turnwould ﬁt well with a hypothesis
that these animals had exposure to sewage derived frommany different
people, with different histories of antimicrobial exposure, whereas
wildlife at theCentral and FarmSiteswould have exposure to less varied
sources and drivers. This would still, however, leave unanswered the
questions of what might be the drivers that led to such high MDR prev-
alence overall, whydifferent animals in the samepopulationmight have
such different exposure histories and why the Farm Site and not the
Central Site had the lowest MDR prevalence.
Themost commonMDR resistance proﬁle encountered in this study
was combined resistance to ampicillin, colistin and ciproﬂoxacin
(Table 2). A high prevalence of resistance to ampicillin was expected
as this beta-lactam antibiotic is frequently used in both human and vet-
erinary medicine and resistance is common not only in clinical samples
(Briñas et al., 2002) but has also been described previously in wild ro-
dents (Arnold et al., 2016, Williams et al., 2011). It is commonly
plasmid-encoded and associated with MDR, as in this study where
83% of the ampicillin resistant isolates were resistant to three or more
antibiotics and 23% to ﬁve or more antibiotics (Table 2). A high preva-
lence of phenotypic resistance to colistin was neither expected nor has
been described previously in wild rodents, although colistin-resistant
E. coli strains have been isolated from waterbird faeces (Wu et al.,
2018). Colistin resistance genes have been demonstrated in waste-
impacted river water (Wu et al., 2018), and especially at STPs
(Hembach et al., 2017). Although chromosomally-encoded colistin re-
sistance has been described for many years, its prevalence was histori-
cally generally low. The recent discovery of the mcr-1 gene, that
confers colistin resistance and is plasmid encoded, enabling rapid hori-
zontal transmission of resistance, (Liu andWong, 2013) is of great clin-
ical concern as colistin is now a ‘last line’ antibiotic used for treating
MDR infections in humans (Velkov et al., 2013). The high prevalence
of colistin resistance found in our study (35–40%), along with most co-
listin resistant isolates being MDR (87% resistant to three or more anti-
biotics and 26% to ﬁve or more antibiotics) is suggestive of horizontal
transmission although screening for the mcr-1 gene by PCR was nega-
tive. However, other plasmid-encoded genes for colistin resistance
have been subsequently described (Xavier et al., 2016), and further
characterisation of the underlying mechanism of the colistin resistance
Table 3
Number of AmpC and ESBL producing E. coli isolates for bird and mammal samples collected at the Farm (livestock waste dominated), Central (no waste source) and STP (human waste
dominated) sites. The percentages in brackets were calculated across all 53 cefpodoxime resistant isolates that were tested for AmpC and ESBL activity.
Site Mammal Bird
AmpC ESBL AmpC & ESBL Negative AmpC ESBL AmpC & ESBL Negative
Farm 4 (8%) 0 2 (4%) 5 (9%) 0 0 0 2 (4%)
Central 6 (11%) 2 (4%) 1 (2%) 4 (8%) 1 (2%) 0 0 0
STP 7 (13%) 4 (8%) 3 (6%) 7 (13%) 4 (8%) 0 0 1 (2%)
Total 17 (32%) 6 (12%) 6 (12%) 16 (30%) 5 (9%) 0 0 3 (6%)
Fig. 4.Mutations of ciproﬂoxacin-resistant E. coli isolated from small mammals (blue boxes). Translated sequences of gyrase A gene from ciproﬂoxacin resistant E. coli isolates compared to
the known sensitive reference strain K-12.
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found in in our study is underway. Seven out of the nine ciproﬂoxacin
resistant isolates contained four nonsynonymous mutations in the gyr-
ase A gene (Fig. 4), which had been reported previously, and two had
mutations that have not previously been reported in E. coli. Wildlife
can, therefore, harbour and disperse novel and/or clinically important
ARGs in the environment.
In terms of other clinical important resistances, cefpodoxime resis-
tance is a common indicator of ESBL production (Oliver et al., 2002),
also of major concern in humanmedicine. From the 53 cefpodoxime re-
sistant E. coli isolated from wildlife, six were ESBL producers, 22 were
AmpC and six were positive for both ESBL and AmpC production
(Table 3). ESBLs have previously been detected in E. coli isolates from
a range of wildlife taxa, for example, 32% of E. coli isolates obtained
from gulls' faeces (Simões et al., 2010), and such ﬁndings have been as-
cribed to contact with human waste. In our study, signiﬁcantly more
ESBL and/or AmpC – producing E. coli were found in wildlife samples
collected from the STP Site, which suggests that human waste may be
a factor driving ESBL/AmpC resistance in the environment.
4.3. Conclusions
Taken together, the results of this study support those of previous
studies in that they conﬁrm that wildlife commonly harbour ARB.
Whether or not wildlife might be a source for onward transmission to
domestic animals or to humans has not been directly examined. Our
study was more concerned with beginning to investigate the drivers
of AMR in wildlife, and in particular the role that anthropogenic
waste, whether of directly human or domestic animal origin, might
play in developing and maintaining that resistance. Diverse patterns of
resistance were found in E. coli from wildlife in this study, suggesting
variation within and between host taxa, between individuals, and over
time. Overall, study site was not associated clearly with AMR, MDR or
resistance patterns. However, resistance to antibiotics used only in
human medicine was more prevalent at the STP site than the Farm
and Central sites. Thus, the drivers of AMR in wildlife appear to be
more complex than simple anthropogenic causes. Consequently, care
needs to be taken if wildlife are to be used as sentinels of environmental
AMR or pollution.
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